The historical rank and industry rank for Lotus Eye Hospital & Institute's Net Margin % or its related term are showing as below:
BOM:532998'
s Net Margin % Range Over the Past 10 Years
Min: 0.15 Med: 3.81 Max: 8.87
Current: 0.15
BOM:532998's Net Margin % is ranked worse than 64.11% of 666
companies
in the Healthcare Providers & Services industry
Industry Median: 2.895
vs BOM:532998: 0.15
Lotus Eye Hospital & Institute (BOM:532998) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Lotus Eye Hospital & Institute Net Margin % Related Terms
Lotus Eye Hospital & Institute Net Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:532998 vs HCA, THC, DVA: Net Margin % Comparison
For the Medical Care Facilities subindustry, Lotus Eye Hospital & Institute's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Lotus Eye Hospital & Institute Net Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Lotus Eye Hospital & Institute's Net Margin % distribution charts can be found below:
* The bar in red indicates where Lotus Eye Hospital & Institute's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lotus Eye Hospital & Institute (BOM:532998) has a Net Margin % of -2.35% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Lotus Eye Hospital & Institute and its competitors. Over the past decade, Lotus Eye Hospital & Institute's Net Margin % has ranged from 0.15 to 8.87. According to the industry distribution chart, Lotus Eye Hospital & Institute ranks #427 out of 666 companies in the Healthcare Providers & Services industry, placing it in the top 64.1%.
Is Lotus Eye Hospital & Institute's Net Margin % too high?
Lotus Eye Hospital & Institute's current Net Margin % is -2.35%. Over the past 10 years, this metric has ranged from a low of 0.15 to a high of 8.87. Based on the distribution chart, Lotus Eye Hospital & Institute ranks #427 out of 666 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Lotus Eye Hospital & Institute has a GF Score™ of 67/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Lotus Eye Hospital & Institute's Net Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Lotus Eye Hospital & Institute ranks #427 out of 666 companies for Net Margin %. This places Lotus Eye Hospital & Institute in the lower half of its industry. The industry median Net Margin % is 2.90. Historically, Lotus Eye Hospital & Institute's own Net Margin % has ranged from 0.15 to 8.87 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Healthcare Providers & Services company?
The median Net Margin % among Healthcare Providers & Services companies is 2.90, based on 666 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Lotus Eye Hospital & Institute and its competitors. For the Healthcare Providers & Services industry, the median Net Margin % is 2.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Lotus Eye Hospital & Institute's current Net Margin % is -2.35%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lotus Eye Hospital & Institute stock overvalued right now?
Based on GuruFocus' analysis, Lotus Eye Hospital & Institute (BOM:532998) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹91.85, compared to a current price of ₹116.85 — trading 27.2% above its estimated fair value. The current Net Margin % is -2.35%. Lotus Eye Hospital & Institute's overall GF Score™ is 67/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Lotus Eye Hospital & Institute (BOM:532998), the current Net Margin % is -2.35% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Lotus Eye Hospital & Institute (BOM:532998) Overvalued in 2026?
Based on GuruFocus' analysis, Lotus Eye Hospital & Institute stock appears to be overvalued.
The current stock price of ₹116.85 is trading 27.2% above its estimated GF Value™ of ₹91.85.
GuruFocus considers Lotus Eye Hospital & Institute to be Modestly Overvalued.
Key valuation signals for BOM:532998:
Net Margin %: -2.35%
GF Value™: ₹91.85 vs. price of ₹116.85 (27.2% above fair value)
No single metric tells the full story. See the BOM:532998 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Lotus Eye Hospital & Institute Business Description
Lotus Eye Hospital & Institute Ltd is an India-based eye care hospital. It is engaged in providing treatment and care for eye diseases and disorders. It offers treatment services for eye conditions like refractive error, retina and uvea, cornea, glaucoma, pediatric, orbit and oculoplasty, neuro-ophthalmology, and binocular vision. In addition, the company also operates an eye bank for functioning eye donation activities. The company mainly operates in India and generates revenue by providing medical services, pharmacy sales, contact lenses, and optical, of which the majority of the revenue is derived from providing segmmedical services.
67GF Score
Get the complete analysis for BOM:532998
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:532998 has been successfully added to your 
